HQ's Heart-Drug Generic Would Flout Baxter Deal, Judge Says
A New Jersey federal judge has blocked HQ Specialty Pharma Corp. from seeking the U.S. Food and Drug Administration's approval for a new generic version of Baxter Healthcare Corp.'s antiarrhythmic drug...To view the full article, register now.
Already a subscriber? Click here to view full article